Sakar Healthcare shares rise after Q2 profit jumps 149%
Sakar Healthcare shares gained on Monday after Q2 FY27 net profit rose 149% year on year to Rs.11.30 crore, according to a Moody's report on the results.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Shares of Indian drugmaker Sakar Healthcare rose in Monday's session, according to Moody's, after the company reported results for the quarter ended 30 September 2026. The stock opened at Rs.943.50, compared with Friday's close of Rs.885, and reached an intraday high of Rs.949.80.
Net profit for Q2 FY27 rose 149% year on year to Rs.11.30 crore from Rs.4.54 crore. Revenue from operations grew 51.9% to Rs.87.41 crore, while EBITDA climbed 114% to Rs.24.34 crore, lifting the EBITDA margin to 28% from 20%. The company credited new oncology approvals, steady demand across regions and cost control.
The shares fell 17.81% over the past month but are up 129.42% year to date and 503.82% over five years. Managing Director Sanjay Shah said the quarter brought meaningful progress in regulatory approvals, technology transfers and global market access.
why it matters
Strong profit growth stands in contrast to the sharp monthly decline in the shares. The analysts quoted by the source focus on technical levels, mainly resistance near Rs.980, rather than on the fundamental picture.
tags
instruments
sources
- Multibagger stock rises 4.5% after Q2 results 2026 - Up 500% in 5 years; will rally continue? Experts' views, target, SL — Moody's, 26 October 2026 at 13:13 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗